Myhealth Newington Hair Restoration

Hair loss due to androgenetic alopecia (AGA)

Androgenetic alopecia is condition that affects up to 50 percent of males and females that results in progressive loss of terminal hair of the scalp any time after puberty.

Men – hair loss in the vertex and frontotemporal regions.

Women – hair loss in the crown and top of head starting at the parting.

Plate Rich Plasma (PRP) Therapy for AGA

Evidence for PRP therapy for AGA goes as far back as 2006 study by Uebel et al. Harvard Medical School has published multiple publications in recent times.

PRP therapy uses the patient’s own blood, which is processed to concentrate platelets rich in healing factors before being injected to the affected area.

PRP injections promote hair growth via multiple mechanisms including;

  • Growth factor release
  • Follicular stimulation
  • Blood flow increasement
  • Inflammation reduction
  • Hair cycle enhancement


Low-Level Laser Therapy (LLLT) for AGA

LLLT, commonly known as red light therapy, enhances the stimulation of mitochondria located in hair bulge stem cells. This then leads to increased adenosine triphosphate to activate cellular proliferation, migration, and oxygenation, which consequently promote hair growth. Studies on LLLT have been done since the 1960s and in 2007, the first cleared LLLT device was introduced by the Food and Drug Administration (FDA) in the United States (US).

Combination therapy for AGA

At Myhealth Newington, combination therapy of both PRP and red light therapy are available to maximise hair restoration.

The red light therapy machine at Newington is Theradome PRO LH80, FDA cleared in the US.

Book a Consultation

Initial consultation with Dr Joshua Lee is essential to determine if PRP and/or red light therapy are right for you.

Please note: PRP therapy and red light therapy are not covered by Medicare and will be billed privately.

To book an appointment, please call and inform reception that your appointment is regarding hair restoration with Dr Joshua Lee.